Agent5Seven topics. One clear view.
Agent5

The latest AI news at a glance: seven topics, and a short, plain-English read on the stories. Free, no account.

Product
HomeHow it worksFAQAboutHow we fact-checkBlog
News
All newsModels & ReleasesFunding & DealsBenchmarksAgents & ProductsHardware & ComputePolicy & DramaRobotics
More
AdvertisePressPrivacyTerms
© 2026 Agent5
Agent5
Blog
Agent5
Blog
  1. Home›
  2. News›
  3. Funding & Deals›
  4. Eka Robotics raises $150M for robot scaling
Models & Releases29Funding & Deals13Benchmarks11Agents & Products52Hardware & Compute22Policy & Drama29Robotics10
Funding & Deals

Eka Robotics raises $150M for robot scaling

The Robot Report: Eka Robotics raises $150M to scale its vision-force-action model for robots

Eka says its model can generalize across objects, tasks, and environments. | Source: Eka Robotics Eka Robotics this week said it has raised $150 million in Series A funding. The startup said the new funding will help it scale its technology and customer deployments. Founded in 2024, Eka is building a vision-force-action (VFA) model to develop an intuition of physics through reinforcement learning at scale. The Cambridge, Mass.-based company said that robots using its AI can pick a wide variety o

Get smart on it

A robotics startup has raised funding to scale its vision-force-action model, an artificial intelligence approach designed to give robots an intuition for physics through reinforcement learning rather than by mimicking human movements. The model enables robots to handle a wide variety of objects outside their training data and perform tasks like picking items at high speeds or manipulating objects such as screwing in light bulbs. The company argues that robots need to master physics and jointly reason about vision and forces to become truly general-purpose, and that simulation learning combined with real-world deployment represents a scalable path toward this goal. This funding round reflects investor interest in advancing dexterous manipulation, the capability for robots to perform complex physical tasks reliably and efficiently in real-world conditions.

Relevant courses

Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.

Browse AI courses on Maven →
Sources
The Robot Report ↗
The biggest AI stories, once a day

One short email a day with the stories that matter. Free. Unsubscribe with one click.

Related news
Funding & DealsOpen story →

OpenAI working on new $30B raise at $1.25T valuation ahead of IPO

Should OpenAI command an over $1 trillion valuation with this round, it would break records as the most highly valued private company ever.

Also reported by SiliconANGLE and The Decoder

Funding & DealsOpen story →

OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.

Also reported by SiliconANGLE and The Decoder

Funding & DealsOpen story →

DeepSeek reportedly raises $15B days after US restrictions

DeepSeek has reportedly raised $15 billion in one of China's largest funding rounds, just days after the US ordered federal agencies to remove its technology over national security concerns.

Funding & DealsOpen story →

Otter.ai raises $320M in funding for its AI meeting assistant

Otter.ai Inc., the developer of a popular artificial intelligence meeting assistant, today announced that it has raised $320 million in funding. The capital came entirely from General Catalyst’s Customer Value Fund. The investment vehicle provides startups with financing for sales and marketing initiatives. General Catalyst doesn’t take a stake in portfolio companies, but instead receives […] The post Otter.ai raises $320M in funding for its AI meeting assistant appeared first on SiliconAN

Funding & DealsOpen story →

AI drug development startup Pathos AI closes $237M investment

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NEA and General Atlantic. Pathos is developing cancer drugs […] The post AI drug development startup Pathos AI closes $237M investment appeared first on SiliconANGLE.

Funding & DealsOpen story →

Meta to create a new class of shares to fund AI push

Meta says it's issuing a new class of shares to fund its AI initiatives. As part of its third-quarter earnings report released on Wednesday, the company says the non-voting stock will also go toward potential acquisitions and employee compensation, with trading beginning in 2027. "The scale of investment required to compete, sustain growth, expand infrastructure, and pursue new strategic initiatives amidst the AI transformation taking place in the industry is significant," Meta

Also reported by TechCrunch